Featured information
Involvement of patients and consumers in the Agency's activities
Patients and consumers are the end-users of the medicines that the European Medicines Agency evaluates, so they are key stakeholders with specific knowledge and expertise to offer the Agency.
The Agency is committed to maintaining a strong working relationship with patients and consumers and is interacting with a growing number of patients’ and consumers’ organisations.
See more information on the Agency's work with patients and consumers.
Searching for medicines by therapeutic area
It is possible to browse for a medicine by therapeutic area. The Agency categorises each medicine it assesses using a taxonomy which can be easily browsed. Go to European public assessment reports (EPARs) and use the 'browse by therapeutic area' tab.
Beware of falsified medicines!
Falsified medicines are fake medicines that may enter the supply chain illegally. Be careful about the way you buy medicines. Find more information on falsified medicines.
Search for herbal medicines
The Agency is responsible for supporting the harmonisation of herbal medicinal products in Europe. Search for herbal medicines assessed by the Agency's Committee on Herbal Medicinal Products.
News for patients and carers
-
17/06/2013
European Medicines Agency’s Management Board endorses revised EMA code of conduct
At its meeting held on 13 June 2013, the European Medicines Agency’s (EMA's) Management Board adopted the revised EMA code of conduct, which aims to ensure that the Agency maintains the highest professional standards of integrity, transparency and independence. ... Read more
-
14/06/2013
Registration opens for workshop on EMA-HTA parallel scientific advice in drug development
The European Medicines Agency (EMA) is inviting expressions of interest in attending its workshop on parallel scientific advice in drug development with health-technology-assessment (HTA) bodies on 26 November 2013. ... Read more
-
14/06/2013
PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the effects of the painkiller diclofenac on the heart and circulation when given systemically (by means such as capsules, tablets or injections) are similar to those of selective COX-2 inhibitors, another group of painkillers. ... Read more
-
14/06/2013
PRAC recommends restricting the use of flupirtine-containing medicines
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of flupirtine-containing medicines and recommended restrictions in their use. ... Read more
-
14/06/2013
PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl starch
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded following a review of the available evidence that the benefits of infusion solutions containing hydroxyethyl starch (HES) no longer outweigh their risks and therefore recommended that the marketing authorisations for these medicines be suspended. ... Read more
- See all News for patients and carers
Events of interest
-
26/11/2013
EMA
European Medicines Agency / health-technology-assessment-body workshop on parallel scientific advice in drug development
The European Medicines Agency (EMA) is holding a one-day workshop on parallel scientific advice with health-technology-assessment (HTA) bodies on evidence-generation in human-medicine development. The workshop is a joint undertaking of the EMA, HTA bodies and developers. Registration open until 30/08/2013. Places limited. ... Read more
-
06/06/2013
EMA
Patients' and Consumers' Working Party
The participants are discussing issues in relation to their general involvement in the European Medicines Agency's activities, giving particular focus to preparation for the election of a new co-chair, Agency training, feedback from the European Patients' Academy on Therapeutic Innovation, public summaries for herbal medicines, the European Union Clinical Trials Register, a workshop on patient-support programmes and patient representation on the Agency's Management Board. Registration by invitation only. ... Read more
-
05/06/2013
Patients' and Consumers' Working Party and Healthcare Professionals' Working Group joint meeting
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. The participants will be discussing issues in relation to their general involvement in the European Medicines Agency’s activities, giving particular focus to supply shortages, feedback from the Agency workshop on medication errors, benefit-risk-assessment visualisation tools and the communication strategy on additional monitoring. ... Read more
-
27/02/2013 - 28/02/2013
EMA
Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. The participants are discussing issues in relation to their general involvement in the Agency's activities, giving particular focus to the communication on safety referrals and risk communication, the implementation of the new pharmacovigilance legislation and falsified medicines. ... Read more
-
28/02/2013 - 01/03/2013
EMA
European Union regulatory workshop on medication errors
The workshop is organised by the European Union regulatory network and is aimed at raising awareness of this important public-health issue, discussing the new legal requirements for reporting medication errors and developing best practice among stakeholders. Preregistration open until 21/12/2012. Registration closed. ... Read more
- See all Events of interest
Information for:
Find information for...
Search for medicines
